This cutting-edge reference book discusses the biomedical applications of nanomaterials. It covers different types of nanoparticles, such as polymeric nanoparticles, lipoidal nanoparticles, and metallic nanoparticles. It discusses the current trends and challenges in the development of safe biomedicines. The book reviews FDA-approved medicines, nanohybrid systems for early-stage diagnosis and treatment of diseases, advanced approaches of cost-effective bio-imaging, and theragnostics. It also covers the basic design and fundamental understanding of surface-engineered biomedicine. The book is meant for experts in the healthcare industry as well as post-graduates in biomedical engineering and nanotechnology.
Dr Rohit Srivastava is Dr Shanti Swarup Bhatnagar awardee, currently working as a Professor and Head at the Indian Institute of Technology Bombay. He completed his Master of Science and PhD degree in Biomedical Engineering from Louisiana Tech University, Ruston, LA, USA, for which he received the best student of the year award in 2005. Dr Srivastava holds various awards such as Healthcare Innovation Worldcup Award 2013, DBT IYBA Award 2013, DBT Tata Innovation Fellowship, Stanford MedTech Award 2016, DBT National Bioscience Award 2016, Shri Om Prakash Bhasin Award 2018, Abdul Kalam Technology Innovation National Fellowship, etc. Additionally, Dr Rohit Srivastava is an elected Fellow of the Royal Society of Chemistry (FRSC), Fellow of the Royal Society of Biology (FRSB), Fellow of NASI, and Fellow of INAE, etc. Dr Srivastava has published more than 200+ articles in international journals and conference proceedings with an h-index of 37. Further, he has participated in several book chapters and books. Nationally and internationally, His lab receives grants for most of all advanced science and technology domains. More than 130+ of his current ideas have been submitted as patents, and design applications to the US and Indian Patent Office, with several of them, have been approved.
Dr Sujit Kumar Debnath is working as an Industrial Post-Doctoral Fellow at Applied Materials India Pvt Ltd. He has completed his PhD in Pharmacy from Gujarat Technological University, Ahmedabad, in 2018. Afterward, he joined as Institute Post-Doctoral Fellow at the Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, India. He has more than 14 years of teaching and research experience. Dr Sujit works on smart and novel drug delivery systems using nanoparticulate approaches. He is well-versed in drug delivery, pre-clinical studies, toxicity, chromatographic estimation, and many more. He holds the GUJOST award from Gujarat Council on Science and Technology, Govt. of Gujarat under the Department of Science and Technology (DST). Nationally and internationally, Dr Sujit has been actively engaged in different collaborative projects. His contribution to science has gotten a brilliant reception from the worldwide scientific community. He has published 24 articles in various high-impact renowned journals and 3 book chapters in reputed publishers. He is frequently appointed as a guest lecturer. He also serves as an active reviewer in many reputable journals.
Dr Rajendra Prasad is currently working as an Assistant Professor at the Indian Institute of Technology-BHU, Varanasi, India. Before this position, he had postdoctoral experience from (i) Tufts University, Medford, MA, USA, (ii) Technion-Israel Institute of Technology, Haifa & NOVA Medical School, Faculdade de Ciências Médicas Campo Mártires da Pátria, Lisboa, Portugal and (iii) Indian Institute of Technology, Bombay, Powai, India. He works in cancer theranostics for solid tumor imaging and ablation. In 2017, Dr. Prasad earned his PhD degree from CSIR-National Chemical Laboratory, Pune, India, on multifunctional hybrid nanomaterials design for cancer theranostics. Dr Prasad mainly focuses on clinically relevant nanomedicines for cancer diagnosis and therapeutics. He has designed chemically conjugated multimode contrast and therapeutic agents such as liposomes, NanoBiosomes, Gold Nanorods, porous silica, drug-conjug ated hybrids, etc., and has investigated them in pre-clinical models. He is well-versed in pre-clinical trials and light-mediated combination cancer therapeutics. To date, he has published about 23 research articles in top-tier journals, about 11 patents, 7 trademarks, 5 journal cover arts, and 2 book chapters with an h-index of 13. Dr Prasad holds awards like the best paper award, PBC Fellow, SAS Fellow, etc.
